Skip to content

Text · Amendment list

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest

Report A-10-2025-0272-AM-256-257 · COM(2025)0102 – C10-0048/2025 – 2025/0102(COD)

Kind
Amendment list A-10-2025-0272-AM-256-257
Date
14 January 2026
More facts (2)
Reference
COM(2025)0102 – C10-0048/2025 – 2025/0102(COD)
More

Text

The text as parsed from the official Word file. Every paragraph has a link (¶) and can be saved to a project as a passage.

14.1.2026 A10-0272/256

Amendment 256

Vlad Vasile-Voiculescu

on behalf of the Renew Group

Report A10-0272/2025

Tomislav Sokol

(COM(2025)0102 – C10-0048/2025 – 2025/0102(COD))

Proposal for a regulation

Recital 12 a (new)

Amendment: Text proposed by the Commission and Amendment
Text proposed by the CommissionAmendment
(12 a) Contraceptives and abortifacient medicinal products are essential in safeguarding sexual and reproductive health rights, gender equality and the full enjoyment of fundamental rights everywhere in the Union. Shortages and supply disruptions affecting these medicinal products of common interest undermine patient safety and contribute to unequal access to healthcare across the Union. In order to safeguard sexual and reproductive health rights and equal access to contraceptive and abortifacient medicinal products for all women in the Union, Member States should ensure availability, affordability and security of supply of these medicinal products of common interest.

Or. en

14.1.2026 A10-0272/257

Amendment 257

Vlad Vasile-Voiculescu

on behalf of the Renew Group

Report A10-0272/2025

Tomislav Sokol

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest

(COM(2025)0102 – C10-0048/2025 – 2025/0102(COD))

Proposal for a regulation

Article 3 – paragraph 1 – point 5

Amendment: Text proposed by the Commission and Amendment
Text proposed by the CommissionAmendment
(5) ‘medicinal product of common interest’ means a medicinal product, other than a critical medicinal product, for which in three or more Member States the functioning of the market does not sufficiently ensure the availability and accessibility to patients in the quantities and presentations necessary to cover the needs of patients in those Member States;(5) ‘medicinal product of common interest’ means a medicinal product, other than a critical medicinal product, for which in three or more Member States the functioning of the market does not sufficiently ensure the availability, affordability and accessibility to patients in the quantities and presentations necessary to cover the needs of patients in those Member States or is designated as an orphan medicinal product pursuant to Article 67 of Regulation (EU).../... [reference to be added after adoption cf. COM(2023)193 final)], or as a contraceptive or abortifacient medicinal product;

Or. en

Connections

The dossier, the decisions on this text and its other versions.

No connections found for this item.

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Retrieved
25 September 2026

Cite as

European Parliament (2026). “A10-0272/256 - Amendement 256 - Vlad Vasile-Voiculescu - au nom du groupe Renew - Rapport A10-0272/2025 - Tomislav Sokol - Cadre visant à renforcer la disponibilité et la sécurité de l’approvisionnement en médicaments critiques ainsi que la disponibilité et l’accessibilité des médicaments d’intérêt commun - (COM(2025)0102 - C10-0048/2025 - 2025/0102(COD))”. Text, 14 January 2026. docId A-10-2025-0272-AM-256-257, reference A10-0272/2025. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/A-10-2025-0272-AM-256-257 (retrieved 25 September 2026). Data: EP Open Data API: document record, https://data.europarl.europa.eu/api/v2/documents/A-10-2025-0272-AM-256-257 (CC BY 4.0).
BibTeX
@misc{epw-text-a-10-2025-0272-am-256-257,
  author = {{European Parliament}},
  title = {{A10-0272/256 - Amendement 256 - Vlad Vasile-Voiculescu - au nom du groupe Renew - Rapport A10-0272/2025 - Tomislav Sokol - Cadre visant à renforcer la disponibilité et la sécurité de l’approvisionnement en médicaments critiques ainsi que la disponibilité et l’accessibilité des médicaments d’intérêt commun - (COM(2025)0102 - C10-0048/2025 - 2025/0102(COD))}},
  year = {2026},
  date = {2026-01-14},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/A-10-2025-0272-AM-256-257}},
  url = {https://news.eu-parl.st-solutions.dev/texts/A-10-2025-0272-AM-256-257},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Text. docId A-10-2025-0272-AM-256-257, reference A10-0272/2025. Data: EP Open Data API: document record (CC BY 4.0)}
}